Tocilizumab as a novel bridging therapy for surgery in dedifferentiated liposarcoma complicated by paraneoplastic leukemoid reaction, severe anemia, and thrombocytopenia: a case report - Quiz - MDSpire

Tocilizumab as a novel bridging therapy for surgery in dedifferentiated liposarcoma complicated by paraneoplastic leukemoid reaction, severe anemia, and thrombocytopenia: a case report

  • By

  • Jinjin Li

  • Ke Li

  • Shanshan Yu

  • Ya Li

  • Jiang Min

  • Zhen Huang

  • Zhengqiang Wei

  • May 5, 2026

  • 0 min

Share

Original Source(s)

Tocilizumab as a novel bridging therapy for surgery in dedifferentiated liposarcoma complicated by paraneoplastic leukemoid reaction, severe anemia, and thrombocytopenia: a case report

  • by Jinjin Li, Ke Li, Shanshan Yu, Ya Li, Jiang Min, Zhen Huang, Zhengqiang Wei

  • May 5, 2026

Related Content

Utilizing Erythrocyte Lifespan as a Predictor for Moderate to Severe Anemia in Patients with Advanced Gastric Cancer Following Anti-Tumor Treatments: A Prospective Investigation

Clinical Reasoning in Practice: Implementing High-Value Care When Data Discrepancies Arise

CRISPR Therapy Raises Fetal Hemoglobin in Sickle Cell Disease

An investigational Cas12a-edited stem cell treatment sharply boosted HbF and largely eliminated vaso-occlusive crises in an early trial

  • April 13, 2026

  • 2 min